Maryland State Retirement & Pension System Buys New Position in ICU Medical, Inc. (NASDAQ:ICUI)

Maryland State Retirement & Pension System acquired a new stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 8,923 shares of the medical instruments supplier's stock, valued at approximately $890,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. CWM LLC boosted its stake in ICU Medical by 341.2% during the fourth quarter. CWM LLC now owns 578 shares of the medical instruments supplier's stock valued at $58,000 after buying an additional 447 shares during the last quarter. SG Americas Securities LLC bought a new stake in ICU Medical in the fourth quarter worth $106,000. Private Trust Co. NA raised its stake in ICU Medical by 273.8% during the fourth quarter. Private Trust Co. NA now owns 1,200 shares of the medical instruments supplier's stock valued at $120,000 after purchasing an additional 879 shares in the last quarter. Knights of Columbus Asset Advisors LLC lifted its position in ICU Medical by 16.7% during the third quarter. Knights of Columbus Asset Advisors LLC now owns 1,848 shares of the medical instruments supplier's stock valued at $220,000 after purchasing an additional 264 shares during the last quarter. Finally, Xponance Inc. grew its stake in shares of ICU Medical by 17.8% in the 3rd quarter. Xponance Inc. now owns 2,902 shares of the medical instruments supplier's stock worth $345,000 after buying an additional 439 shares in the last quarter. Institutional investors own 96.10% of the company's stock.

Analyst Ratings Changes

Separately, KeyCorp lifted their price objective on shares of ICU Medical from $134.00 to $136.00 and gave the company an "overweight" rating in a report on Wednesday, February 28th.

Insider Buying and Selling

In related news, insider Ben Sousa sold 2,000 shares of the business's stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $105.55, for a total value of $211,100.00. Following the transaction, the insider now owns 1,319 shares in the company, valued at approximately $139,220.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Ben Sousa sold 2,000 shares of ICU Medical stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $105.55, for a total transaction of $211,100.00. Following the completion of the sale, the insider now directly owns 1,319 shares in the company, valued at approximately $139,220.45. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Daniel Woolson sold 791 shares of the company's stock in a transaction on Friday, March 15th. The shares were sold at an average price of $98.27, for a total value of $77,731.57. Following the completion of the sale, the vice president now directly owns 13,980 shares in the company, valued at approximately $1,373,814.60. The disclosure for this sale can be found here. Insiders have sold 26,262 shares of company stock worth $2,756,632 in the last ninety days. 6.70% of the stock is owned by corporate insiders.

ICU Medical Trading Up 0.7 %

Shares of NASDAQ ICUI traded up $0.72 during trading on Friday, hitting $107.10. 291,915 shares of the company were exchanged, compared to its average volume of 191,823. ICU Medical, Inc. has a 12-month low of $78.28 and a 12-month high of $208.48. The firm has a market capitalization of $2.61 billion, a PE ratio of -87.07 and a beta of 0.72. The company has a fifty day moving average price of $100.53 and a 200-day moving average price of $97.18. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.06 and a current ratio of 2.53.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.39. The firm had revenue of $587.86 million during the quarter, compared to the consensus estimate of $564.77 million. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. As a group, equities research analysts expect that ICU Medical, Inc. will post 3.53 EPS for the current year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.